Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Nat Commun ; 13(1): 7529, 2022 12 07.
Artigo em Inglês | MEDLINE | ID: mdl-36477027

RESUMO

Precision oncology research is challenging outside the contexts of oncogenic addiction and/or targeted therapies. We previously showed that phosphoproteomics is a powerful approach to reveal patient subsets of interest characterized by the activity of a few kinases where the underlying genomics is complex. Here, we conduct a phosphoproteomic screening of samples from HER2-negative female breast cancer receiving neoadjuvant paclitaxel (N = 130), aiming to find candidate biomarkers of paclitaxel sensitivity. Filtering 11 candidate biomarkers through 2 independent patient sets (N = 218) allowed the identification of a subgroup of patients characterized by high levels of CDK4 and filamin-A who had a 90% chance of achieving a pCR in response to paclitaxel. Mechanistically, CDK4 regulates filamin-A transcription, which in turn forms a complex with tubulin and CLIP-170, which elicits increased binding of paclitaxel to microtubules, microtubule acetylation and stabilization, and mitotic catastrophe. Thus, phosphoproteomics allows the identification of explainable factors for predicting response to paclitaxel.


Assuntos
Neoplasias da Mama , Paclitaxel , Feminino , Humanos , Neoplasias da Mama/tratamento farmacológico , Quinase 4 Dependente de Ciclina , Genômica , Paclitaxel/farmacologia , Medicina de Precisão
2.
Luminescence ; 37(12): 2129-2138, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36327119

RESUMO

In this article bacterial carbonate mineralization treatments are proposed as a novel strategy for decayed fossils and palaeontological heritage conservation; specifically, by means of inoculation of Myxococcus xanthus, a bacterium of proven effectiveness in ornamental stone bioconsolidation. Bioconsolidation treatments can be very effective, stable, nontoxic, environmentally friendly, and chemically compatible with fossil heritage. The method reproduces what nature has been doing for millennia with fossils that have been permineralized by bacterial calcium carbonate precipitation. There is, however, some concern that bacterial inoculation could lead to the growth of undesirable microbiota, which could subsequently damage the fossil substrate. Because of this, the use of bacteria on heritage items must be meticulously monitored and analysis strategies should be carried out to detect bacteria viability during and after treatments. For this purpose, adenosine triphosphate assay is proposed in this article as a fast, affordable, portable, and easy-to-use system for conservators. as ATP assay results are relative and difficult to relate to colony forming unit, this study aims to improve their applicability by examining the correlation between ATP analysis and total viable bacteria count in the specific case of M. xanthus. This research provides reference and correlatable data to obtain an approximate estimation of M. xanthus viable bacterial colonies based on relative light unit data.


Assuntos
Trifosfato de Adenosina , Myxococcus xanthus , Carbonato de Cálcio , Células-Tronco
3.
J Small Anim Pract ; 61(6): 354-362, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32346883

RESUMO

OBJECTIVES: To describe reduction techniques and clinical outcome in a series of traumatic elbow luxations in cats. MATERIALS AND METHODS: Retrospective review of unilateral elbow luxations treated at five specialist referral centres. Data included signalment, aetiology, concurrent injuries, luxation direction, time to reduction, primary reduction technique, surgical procedure and complications. Cases were excluded if reduction technique was unknown. Telephone owner questionnaire follow-up was completed using a Feline Musculoskeletal Pain Index. RESULTS: Thirty-two cats were included. Lateral luxations were most common (n = 21). Time (hours) until attempted initial closed reduction was <24 (n = 12), 24-48 (n = 13), >48 (n = 3) or unrecorded (n = 4). Luxation was treated by closed reduction alone (n = 7) or by surgery (n = 25); 14 of 25 cases underwent primary surgical reduction and 11 of 25 were secondary procedures following failure of closed reduction. Transcondylar bone tunnels and circumferential suture (n = 19) was the most commonly used surgical technique. Catastrophic (n = 1), major (n = 11) and minor complications (n = 5) were recorded; reluxation occurred more frequently after closed reduction (n = 8) than after open reduction with fixation (n = 0). Feline Musculoskeletal Pain Index data were available for 12 cats; outcome was good-excellent in all 12, with a median function score of 64.5/68 (range: 55-68) and a median pain score of 0/15 (range: 0-5). Outcome was not associated with reduction technique. CLINICAL SIGNIFICANCE: Elbow reluxation occurred in 61% of cats following primary closed reduction but did not occur in any open reduction cases. Reluxation rate increased with duration from injury. Most cats had good-excellent owner-assessed outcome, regardless of reduction technique.


Assuntos
Doenças do Gato , Luxações Articulares/veterinária , Animais , Gatos , Membro Anterior , Estudos Retrospectivos , Resultado do Tratamento
4.
J Small Anim Pract ; 61(4): 241-246, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32003012

RESUMO

OBJECTIVES: To determine the risk of lameness and the rate of subsequent medial patellar luxation surgery in dogs that present with occult Grade II medial patellar luxation. MATERIALS AND METHODS: Retrospective owner survey and review of clinical records of adult dogs diagnosed with Grade II medial patellar luxation that were initially asymptomatic and managed non-surgically that had a minimum of 4-year follow-up. Clinical notes and owner questionnaires identified dogs that subsequently developed lameness and required surgery on the previously asymptomatic stifle. RESULTS: Thirty-eight dogs were included with an average follow-up of 51 months. Seventeen dogs re-presented for unscheduled contralateral medial patellar luxation surgery at an average of 15 months after initial presentation. A further two dogs had chronic contralateral limb lameness after an average of 33 months after initial surgery and may have been potential surgical candidates. CLINICAL SIGNIFICANCE: Fifty percent of adult dogs presenting with occult Grade II medial patellar luxation subsequently developed chronic lameness or required surgery.


Assuntos
Doenças do Cão , Luxação Patelar/veterinária , Animais , Cães , Estudos Retrospectivos , Joelho de Quadrúpedes , Resultado do Tratamento
5.
Ann Oncol ; 30(8): 1289-1297, 2019 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-31147675

RESUMO

BACKGROUND: This hypothesis-generating trial evaluated neoadjuvant ipatasertib-paclitaxel for early triple-negative breast cancer (TNBC). PATIENTS AND METHODS: In this randomized phase II trial, patients with early TNBC (T ≥ 1.5 cm, N0-2) were randomized 1 : 1 to receive weekly paclitaxel 80 mg/m2 with ipatasertib 400 mg or placebo (days 1-21 every 28 days) for 12 weeks before surgery. Co-primary end points were pathologic complete response (pCR) rate (ypT0/TisN0) in the intention-to-treat (ITT) and immunohistochemistry phosphatase and tensin homolog (PTEN)-low populations. Secondary end points included pCR rate in patients with PIK3CA/AKT1/PTEN-altered tumors and pre-surgery response rates by magnetic resonance imaging (MRI). RESULTS: pCR rates with ipatasertib versus placebo were 17% versus 13%, respectively, in the ITT population (N = 151), 16% versus 13% in the immunohistochemistry PTEN-low population (N = 35), and 18% versus 12% in the PIK3CA/AKT1/PTEN-altered subgroup (N = 62). Rates of overall and complete response (CR) by MRI favored ipatasertib in all three populations (CR rate 39% versus 9% in the PIK3CA/AKT1/PTEN-altered subgroup). Ipatasertib was associated with more grade ≥3 adverse events (32% versus 16% with placebo), especially diarrhea (17% versus 1%). Higher cycle 1 day 8 (C1D8) immune score was significantly associated with better response only in placebo-treated patients. All ipatasertib-treated patients with low immune scores and a CR had PIK3CA/AKT1/PTEN-altered tumors. CONCLUSIONS: Adding ipatasertib to 12 weeks of paclitaxel for early TNBC did not clinically or statistically significantly increase pCR rate, although overall response rate by MRI was numerically higher with ipatasertib. The antitumor effect of ipatasertib was most pronounced in biomarker-selected patients. Safety was consistent with prior experience of ipatasertib-paclitaxel. A T-cell-rich environment at C1D8 had a stronger association with improved outcomes in paclitaxel-treated patients than seen for baseline tumor-infiltrating lymphocytes. This dependency may be overcome with the addition of AKT inhibition, especially in patients with PIK3CA/AKT1/PTEN-altered tumors. CLINICALTRIALS.GOV: NCT02301988.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Terapia Neoadjuvante/métodos , Paclitaxel/administração & dosagem , Piperazinas/administração & dosagem , Pirimidinas/administração & dosagem , Neoplasias de Mama Triplo Negativas/terapia , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Biomarcadores Tumorais/antagonistas & inibidores , Biomarcadores Tumorais/genética , Mama/diagnóstico por imagem , Mama/patologia , Mama/cirurgia , Intervalo Livre de Doença , Método Duplo-Cego , Esquema de Medicação , Feminino , Mutação com Ganho de Função , Humanos , Imageamento por Ressonância Magnética , Mastectomia , Pessoa de Meia-Idade , Terapia Neoadjuvante/efeitos adversos , Estadiamento de Neoplasias , Paclitaxel/efeitos adversos , Seleção de Pacientes , Piperazinas/efeitos adversos , Placebos/administração & dosagem , Placebos/efeitos adversos , Pirimidinas/efeitos adversos , Neoplasias de Mama Triplo Negativas/mortalidade , Neoplasias de Mama Triplo Negativas/patologia
6.
Rev. chil. obstet. ginecol. (En línea) ; 83(6): 606-613, 2018. graf, ilus
Artigo em Espanhol | LILACS | ID: biblio-990875

RESUMO

RESUMEN El carcinoma metaplásico de mama es un tipo de cáncer infiltrante que asemeja un carcinoma de alto grado histológico, pero cuya incidencia es muy baja (< 1%). Desde el punto de vista anatomopatológico presenta un componente mixto epitelial y mesenquimal; siendo lo más característico su comportamiento clínico altamente agresivo junto con unas características anatomopatológicas, inmunohistoquímicas concordantes, como son el HER2/neu negativo, los receptores hormonales negativos, el tamaño tumoral grande y el alto grado histológico. Por todo ello, resulta de especial interés conocer esta entidad, con la finalidad de realizar un diagnóstico preciso y llevar a cabo un tratamiento adecuado en estas pacientes. En el presente artículo se presenta la revisión de dos casos clínicos de cáncer de mama metaplásico, diagnosticados y tratados en nuestro Hospital durante el año 2015 y 2018.


ABSTRACT The metaplastic breast cancer is a subtype of an infiltranting breast cancer and it's usually high grade. However it is a rare subtype of cancer (incidence <1%). This cancer has an epithelial and connective tissues, which has an epithelial invasor ductal breast cancer with high grade and sarcomas breast. The main characteristic of the metaplastic breast cancer is their high agressive behavior as clinical as anatomopathological, which immunohistochemical expression is like a triple negative breast cancer. Because of this we consider that their knowledge is very important with the purpose of being diagnosed in women. In this paper it is showed a revision of two cases of metaplastic breast cancer, whose diagnostic and treatment were reported in our Centre.


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Idoso , Neoplasias da Mama/patologia , Carcinoma/patologia , Metaplasia/patologia , Sarcoma , Neoplasias da Mama/terapia , Neoplasias da Mama/diagnóstico por imagem , Carcinoma/terapia , Carcinoma/diagnóstico por imagem , Mastectomia
7.
J Small Anim Pract ; 58(7): 372-379, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28407253

RESUMO

OBJECTIVE: To report diaphyseal fractures of the proximal tibia following tibial tuberosity advancement without plate stabilisation for the management of cranial cruciate ligament rupture in dogs. METHODS: Members of the British Veterinary Orthopaedic Association's online discussion forum were invited to submit revision cases of tibial diaphyseal fracture following tibial tuberosity advancement without plate fixation. Data collected included signalment, surgical revision technique, pre- and postoperative revision radiographic findings, complications and veterinary assessment. Owners were invited to complete the Liverpool Osteoarthritis in Dogs questionnaire. RESULTS: A total of 17 dogs were included in the study. Eleven dogs had OrthoFoam-wedge modified Maquet procedures and six had the tibial tuberosity advancement rapid procedure. Tibial tuberosity advancement was maintained in 14/17 cases. Postrevision surgery complications occurred in eight cases: minor complications in 3/17 dogs; major in 5/17 and no catastrophic complications. Surgical site infection was the most common complication (4/8). Final clinical outcome found 8/17 of dogs to have excellent, 8/17 satisfactory and 1/17 poor clinical outcome. The median Liverpool Osteoarthritis in Dogs score was 12/52 (range 2 to 28). Final outcome was 6/13 owners that were very satisfied, 2/13 owners indifferent and 5/13 owners very disappointed. CLINICAL SIGNIFICANCE: This is the first case series reporting tibial diaphyseal fractures following tibial tuberosity advancement without plate stabilisation. The authors report here a wide spectrum of potential fixation strategies should one of these fractures occur.


Assuntos
Lesões do Ligamento Cruzado Anterior/veterinária , Ligamento Cruzado Anterior/cirurgia , Cães , Fraturas da Tíbia/veterinária , Animais , Lesões do Ligamento Cruzado Anterior/cirurgia , Diáfises , Cães/lesões , Cães/cirurgia , Feminino , Masculino , Complicações Pós-Operatórias/veterinária , Estudos Retrospectivos , Joelho de Quadrúpedes/cirurgia , Tíbia , Fraturas da Tíbia/cirurgia
8.
Rev. chil. urol ; 82(2): 34-41, 2017. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-906009

RESUMO

Introducción. Aproximadamente un 3% de los hombres que se han sometido a una vasectomía se realizan posteriormente una reversión de ésta con intención de fertilidad. La vasovasostomía (VV) microquirúrgica como técnica de reversión de vasectomía, permite la recanalización de los conductos deferentes, ofreciendo muy buenos resultados. Objetivo. Describir los resultados quirúrgicos y la efectividad de la VV en una serie de pacientes operados mediante una técnica simplificada. Materiales y Métodos. Estudio retrospectivo. Se analizaron antecedentes demográficos y quirúrgicos. Se utilizó una técnica de VV simplificada que consiste en realizar una miniincisión de abordaje (1 cm), sin evaluar el líquido seminal mediante la graduación de Silber y realizar la anastomosis en un plano único con material de sutura no reabsorbible 9-0. Se controló con espermiograma al primer y tercer mes post-cirugía, evaluando concentración espermática, motilidad progresiva, morfología y volumen seminal entre otros. Se calculó la tasa de permeabilidad deferencial (definida como presencia de espermatozoides en el eyaculado) y la tasa de embarazo post VV. Resultados. Un total de 75 pacientes fueron incluidos en el estudio, operados entre agosto de 2009 y julio de 2016 por 2 cirujanos (CP, MM). La edad media (± desviación estándar) de los pacientes y de sus parejas fue de 43,9 ± 6,4 años y 34,4 ± 4,2 años, respectivamente. La mediana del tiempo transcurrido entre la vasectomía y la VV fue de 8 años (2 ­ 21 años). La mediana del tiempo quirúrgico fue de 110 minutos (85 ­ 183 minutos), con menos de un 3 por ciento de complicaciones post-operatorias (todas grado-I según escala Clavien-Dindo). Al primer mes el 93 por ciento de los pacientes tenía espermatozoides en el eyaculado, con una mediana de concentración de 12 x 10


Introducción. Stage I testicular cancer represents the most usual presentation of this disease. Adjuvant therapy (chemotherapy, radiotherapy, surgery) or active surveillance (AS) have been in constant evaluation in the last years. AS has proven to be an excellent treatment option, given its high rates of cancer specific survival. The objective of this study is to evaluate the local experience with stage I testicular cancer patients. Materials y Methods. Retrospective study of 124 patients with testicular cancer in a 5 year lapse. Data of histologic risk factors for progression, disease progression/recurrence, elected treatment and compliance to follow up were recorded. Results. Data was analysed for 97 stage I testicular cancer. 46 out of these patients were submitted to active surveillance. Histologic risk factors from pure seminoma and non seminoma were compared separately. Statistic difference was demonstrated in patients elected to active treatment with rete testis invasion (p: 0.02). No difference was demonstrated in risk factors for non seminoma. Compliance to maintain follow up in the AS group was 57 pertcent. Conclusion: Active surveillance is a valid option of treatment. In our center, this treatment option was associated with low adherence to follow up, which could imply negative consequences to the patients over time. Histologic risk factors are not exclusive factors for the decision of treatment in these patients. (AU)


Assuntos
Masculino , Neoplasias Testiculares , Quimioterapia Adjuvante
9.
J Small Anim Pract ; 57(8): 422-8, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27271244

RESUMO

OBJECTIVES: Limited guidelines exist regarding the optimal treatment of traumatic canine elbow luxation, and there is a lack of information on long-term functional outcome. Here we report reduction and stabilisation techniques for a series of traumatic elbow luxations and describe clinical outcome plus long-term questionnaire-based follow-up. METHODS: Retrospective review of canine traumatic elbow luxations (2006 to 2013) treated at five referral centres. Data recorded included signalment, luxation aetiology, time to reduction, reduction technique, surgical procedure, post-reduction care and complications. Questionnaire follow-up was attempted for all cases with owners completing the Canine Brief Pain Inventory. RESULTS: Thirty-seven dogs were included. The most frequent cause of luxation was road traffic accident (n=22). Twenty cases were treated surgically. Seven dogs suffered major postoperative complications: reluxation (n=6), infection requiring implant removal (n=1). Four of the six reluxations occurred in dogs that had other orthopaedic injuries. Twenty-two owners completed the Canine Brief Pain Inventory questionnaire: there were 13 excellent, 6 very good, 1 good and 2 fair outcomes. Outcome was not associated with the reduction technique. CLINICAL SIGNIFICANCE: Initial closed reduction, followed by surgical stabilisation if unsuccessful, results in good-to-excellent outcomes in the majority of traumatic canine elbow luxations. Reluxation was the most common major complication and there was a higher incidence of reluxation in patients with multiple orthopaedic injuries.


Assuntos
Cães/lesões , Lesões no Cotovelo , Luxações Articulares/veterinária , Animais , Cães/cirurgia , Articulação do Cotovelo/cirurgia , Inglaterra , Feminino , Seguimentos , Luxações Articulares/cirurgia , Coxeadura Animal/cirurgia , Masculino , New South Wales , Procedimentos Ortopédicos/veterinária , Medição da Dor/veterinária , Estudos Retrospectivos , Inquéritos e Questionários , Resultado do Tratamento , Ferimentos e Lesões/cirurgia , Ferimentos e Lesões/veterinária
10.
Curr Oncol ; 22(2): e51-60, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25908921

RESUMO

OBJECTIVE: During clinical practice, it can be challenging, given the lack of response biomarkers, to identify the patients with metastatic breast cancer (mbca) who would benefit most from the addition of bevacizumab to first-line standard chemotherapy. The aim of the present review was to summarize the relevant scientific evidence and to discuss the experience of a group of experts in using bevacizumab to treat mbca. METHODS: A panel of 17 Spanish oncology experts met to discuss the literature and their experience in the use of bevacizumab as first-line treatment for mbca. During the meeting, discussions focused on three main issues: the profile of the patients who could benefit most from bevacizumab, the optimal bevacizumab treatment duration, and the safety profile of bevacizumab. RESULTS: The subset of mbca patients who would benefit the most from the addition of bevacizumab to first-line standard chemotherapy are those with clinically defined aggressive disease. Treatment with bevacizumab should be maintained until disease progression or the appearance of unacceptable toxicity. In the mbca setting, the toxicity profile of bevacizumab is well known and can be managed in clinical practice after adequate training. CONCLUSIONS: This expert group recommends administering bevacizumab as first-line treatment in patients with clinically aggressive disease.

11.
Vet Comp Orthop Traumatol ; 28(3): 199-206, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25757496

RESUMO

OBJECTIVE: To examine perioperative factors affecting surgical site infection (SSI) rate following tibial tuberosity advancement (TTA). STUDY DESIGN: Retrospective case series. SAMPLE POPULATION: 224 stifles in 186 dogs. METHODS: Medical records of dogs that underwent TTA in a single institution were reviewed. Information on signalment, anaesthetic and surgical parameters, as well as occurrence of SSI was recorded. Dogs were followed for a minimum of three months postoperatively. The association between perioperative factors and SSI was assessed using Chi-squared tests and binary logistic regression. RESULTS: The prevalence of SSI was 5.3% (12/224 TTA). Surgical time (p = 0.02) and anaesthesia time (p = 0.03) were significantly associated with SSI. For every minute increase in surgical time and anaesthesia time, the likelihood of developing SSI increased by seven percent and four percent respectively. The use of postoperative antimicrobial therapy was not significantly associated with lower SSI (p = 0.719). Implants were removed in 1.3% of cases (3/224 TTA). CONCLUSIONS: The findings of this study suggest that increased surgical and anaesthesia times are significant risk factors for SSI in TTA, and that there is no evidence that postoperative prophylactic antimicrobial therapy is associated with SSI rate.


Assuntos
Ligamento Cruzado Anterior/cirurgia , Doenças do Cão/etiologia , Infecção da Ferida Cirúrgica/veterinária , Tíbia/cirurgia , Animais , Antibioticoprofilaxia/métodos , Antibioticoprofilaxia/veterinária , Doenças do Cão/cirurgia , Cães/cirurgia , Feminino , Masculino , Procedimentos Ortopédicos/efeitos adversos , Procedimentos Ortopédicos/métodos , Procedimentos Ortopédicos/veterinária , Estudos Retrospectivos , Fatores de Risco , Infecção da Ferida Cirúrgica/etiologia , Infecção da Ferida Cirúrgica/prevenção & controle
12.
Vet Comp Orthop Traumatol ; 28(2): 116-23, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25650590

RESUMO

OBJECTIVE: To retrospectively identify factors that predispose to tibial tuberosity (TT) fracture after tibial tuberosity advancement (TTA) in dogs. METHODS: The medical records and radiographs of a group of control dogs (n = 212) that had TTA surgery (n = 241 procedures) and did not sustain a fracture between 2008 and 2013, and those of 12 dogs that did sustain a fracture (n = 13 procedures) between 2008 and 2013 at two veterinary teaching hospitals were evaluated to determine the effect of signalment, body weight and surgical inaccuracies on TT fracture. Multivariable logistic regression was performed with the occurrence of TT fracture as the outcome variable of interest. RESULTS: Signalment and body weight were not found to be associated with TT fracture. Of the surgical inaccuracies, osteotomy shape (p = 0.003), plate position (p = 0.009), and cage position (p = 0.039) were factors significantly associated with TT fracture. CLINICAL SIGNIFICANCE: This study provides data to support the hypothesis that poor plate position, poor cage position, and narrow distal osteotomy width are associated with TT fracture after TTA. We conclude that it is of paramount importance to pay careful attention to surgical technique in order to reduce this risk.


Assuntos
Doenças do Cão/etiologia , Procedimentos Ortopédicos/veterinária , Complicações Pós-Operatórias/veterinária , Fraturas da Tíbia/veterinária , Animais , Peso Corporal , Doenças do Cão/cirurgia , Cães , Erros Médicos/veterinária , Procedimentos Ortopédicos/efeitos adversos , Procedimentos Ortopédicos/normas , Estudos Retrospectivos , Fatores de Risco , Fraturas da Tíbia/cirurgia
13.
Breast Cancer Res Treat ; 149(2): 385-94, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25528024

RESUMO

Recently, we observed that telomeres of BRCA1/2 mutation carriers were shorter than those of controls or sporadic breast cancer patients, suggesting that mutations in these genes might be responsible for this event. Given the contradictory results reported in the literature, we tested whether other parameters, such as chemotherapy, could be modifying telomere length (TL). We performed a cross-sectional study measuring leukocyte TL of 266 sporadic breasts cancer patients treated with first-line chemotherapy, with a median follow-up of 240 days. Additionally, we performed both cross-sectional and longitudinal studies in a series of 236 familial breast cancer patients that included affected and non-affected BRCA1/2 mutation carriers. We have measured in leukocytes from peripheral blood: the TL, percentage of short telomeres (<3 kb), telomerase activity levels and the annual telomere shortening speed. In sporadic cases we found that chemotherapy exerts a transient telomere shortening effect (around 2 years) that varies depending on the drug combination. In familial cases, only patients receiving treatment were associated with telomere shortening but they recovered normal TL after a period of 2 years. Chemotherapy affects TL and should be considered in the studies that correlate TL with disease susceptibility.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/genética , Telômero/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Mama/tratamento farmacológico , Estudos de Casos e Controles , Estudos Transversais , Feminino , Genes BRCA1 , Genes BRCA2 , Humanos , Estudos Longitudinais , Pessoa de Meia-Idade , Mutação , Fatores de Risco , Telômero/metabolismo , Encurtamento do Telômero , Adulto Jovem
14.
Vet Comp Orthop Traumatol ; 27(2): 148-54, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24441572

RESUMO

OBJECTIVES: To retrospectively compare two clinical subsets of dogs suffering tibial tuberosity (TT) fracture (incidental finding or sudden onset severe lameness) as a complication of tibial tuberosity advancement (TTA) and to report the surgical management and outcome of TT fracture as a complication of TTA. MATERIAL AND METHODS: The medical records of 10 dogs with eleven TT fractures or crest fractures after TTA were reviewed. The outcome and complications were determined from clinical and radiographic follow-up examinations. Limb function was evaluated between six and 12 weeks postoperatively. Owners were contacted by phone for long-term follow-up at least six months after the last examination. RESULTS: Four dogs required surgical stabilization and six dogs had conservative management. In the surgical group, every case experienced a sudden non-weight-bearing lameness after the initial TTA surgery. In three of the four cases an attempt was made to stabilize the TT and crest fracture while maintaining the TT advancement. Postoperative complications were encountered in three of the four surgically treated cases. Functional outcome was considered excellent in seven cases and good in the other three. CLINICAL SIGNIFICANCE: Tibial tuberosity fracture is a complication of TTA that seems to have a favourable prognosis, although it can result in significant morbidity and in some cases revision surgery may be required.


Assuntos
Cães/lesões , Tíbia/cirurgia , Fraturas da Tíbia/veterinária , Animais , Fixação de Fratura/métodos , Fixação de Fratura/veterinária , Coxeadura Animal/etiologia , Coxeadura Animal/cirurgia , Complicações Pós-Operatórias/veterinária , Estudos Retrospectivos , Fraturas da Tíbia/etiologia , Fraturas da Tíbia/cirurgia , Resultado do Tratamento
15.
Vet Comp Orthop Traumatol ; 22(6): 498-504, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19876518

RESUMO

Pancarpal and partial carpal arthrodesis were performed in 22 carpi (20 cats) using various surgical methods. Short and long-term outcomes were assessed using a retrospective review of the case notes and via owner questionnaires. Carpal arthrodesis was associated with complications that did not affect the functional outcome, and in most cases, did not necessitate major revision surgery. Following arthrodesis, the cats did not jump as high, and showed a reduction in their willingness to jump and climb. Based on our results, carpal arthrodesis is a suitable salvage surgery to treat severe carpal injuries in the cat.


Assuntos
Artrodese/veterinária , Gatos/lesões , Membro Anterior/cirurgia , Animais , Osteoartrite/cirurgia , Osteoartrite/veterinária , Complicações Pós-Operatórias , Estudos Retrospectivos , Inquéritos e Questionários , Ferimentos e Lesões/cirurgia , Ferimentos e Lesões/veterinária
16.
Clin Transl Oncol ; 9(5): 317-22, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17525042

RESUMO

INTRODUCTION: The purpose of this phase II study was to evaluate the efficacy and safety of neoadjuvant docetaxel/gemcitabine treatment in a biweekly regimen. MATERIALS AND METHODS: Patients with stage II/III breast cancer were treated with docetaxel (65 mg/m(2)) followed by gemcitabine (2500 mg/m(2)) every 2 weeks for 6 cycles. Patients with a clinical response or stable disease underwent mastectomy or breast-conserving surgery plus axillary dissection. After surgery, patients received 4 cycles of standard doxorubicin 60 mg/m(2) and cyclophosphamide 600 mg/m(2) every 21 days. RESULTS: Thirty-five patients were included in the trial. The overall response rate was 71.4% (95% CI: 53.7-85.4), with 8 complete and 17 partial responses. Breast conservation was possible in 59% of the patients. Toxicity was manageable. CONCLUSIONS: We consider biweekly docetaxel and gemcitabine could be an active and tolerable regimen option in the neoadjuvant setting sequentially with standard adjuvant doxorubicin-cyclophosphamide in patients with stage II or III breast cancer.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Ciclofosfamida/uso terapêutico , Desoxicitidina/análogos & derivados , Doxorrubicina/uso terapêutico , Taxoides/administração & dosagem , Adulto , Idoso , Quimioterapia Adjuvante , Desoxicitidina/administração & dosagem , Docetaxel , Esquema de Medicação , Feminino , Humanos , Pessoa de Meia-Idade , Terapia Neoadjuvante , Estadiamento de Neoplasias , Gencitabina
19.
Eur Heart J ; 23(8): 633-40, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11969278

RESUMO

AIMS: To assess the safety of direct coronary stenting, its influence on costs, duration of the procedure, radiation exposure, clinical outcome and angiographic restenosis. METHODS AND RESULTS: We randomized 416 patients (446 lesions) to direct stent implant or stent implant following balloon pre-dilation. Patients >75 years old, heavily calcified lesions, bifurcations, total occlusions, left main lesions and very tortuous vessels were excluded. Direct stenting was successful in 217/224 lesions (96.8%). No single loss or embolization of the stent occurred. All stents in the group with pre-dilation were effectively deployed. The immediate post-procedure angiographic results were similar with both techniques. Fluoroscopy and procedural time were significantly lower in direct stenting (6.4+/-0.3 and 21+/-0.9 min) than in pre-dilated stenting (9.1+/-0.4 and 27.5+/-1.1 min) (P>0.001). Major adverse cardiac events during hospitalization were one in direct and four in pre-dilated stenting (P=0.05) but there were no significant differences at follow-ups at 1, 6 and 12 months between the two groups. Angiographic reevaluation at 6 months was performed in 94% of the cases. Restenosis rate was 16.5% in direct stenting and 14.3% in pre-dilated stenting (P=ns). CONCLUSIONS: Direct stenting is as safe as pre-dilated stenting in selected coronary lesions. Acute angiographic results are similar but procedural costs, duration of the procedure and radiation exposure are lower in direct stenting. Overall success rate, mid-term clinical outcome and restenosis are similar with both techniques.


Assuntos
Angioplastia Coronária com Balão , Vasos Coronários/cirurgia , Stents , Adulto , Idoso , Implante de Prótese Vascular , Angiografia Coronária , Ponte de Artéria Coronária , Reestenose Coronária/etiologia , Reestenose Coronária/mortalidade , Estenose Coronária/complicações , Estenose Coronária/mortalidade , Estenose Coronária/terapia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/mortalidade , Estudos Prospectivos , Espanha , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento
20.
Rev. Soc. Odontol. La Plata ; 11(20): 20-4, 29-33, 1998. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-242337

RESUMO

La toma de impresiones al paciente totalmente desdentado tiene como objetivo registrar la anatomía de la cavidad bucal para reproducirla en escayola, y poder confeccionar las prótesis a su medida. Exponemos en este artículo los criterios recomendados para conseguir unas buenas impresiones. Aportamos pequeñas sugerencias que pueden facilitar al profesional la adquisición de la destreza necesaria para obtener unas impresiones correctas


Assuntos
Humanos , Pessoa de Meia-Idade , Materiais para Moldagem Odontológica , Técnica de Moldagem Odontológica , Prótese Total/normas , Alginatos/química , Sulfato de Cálcio/normas , Coloides/química , Modelos Dentários/normas , Arcada Edêntula/reabilitação , Arcada Osseodentária/anatomia & histologia , Silicones/química , Acetato de Zinco/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA